Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
Medical footprint expansion with deeper medical grade skin contact material science expertise
EMA’s CHMP advice states that Paxlovid can be used for treatment of adults with Covid-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe disease
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
The data has been shared with the U.S.FDA as part of an ongoing rolling submission for Emergency Use Authorisation
Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
Subscribe To Our Newsletter & Stay Updated
